Evidence map›Paper›PMID 37484960›Full record

ReviewFrontiers in endocrinology2023

The role of m

Daniel Benak, Stepanka Benakova, Lydie Plecita-Hlavata, Marketa Hlavackova

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. The latest progression of N6-methyladenosine (mFrontiers in endocrinology · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Changes of RNA mCell biochemistry and biophysics · 2024
    Article
  17. Epitranscriptomic Regulations in the Heart.Physiological research · 2024
    Review
  18. Review
  19. Article
  20. FTO in health and disease.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Daniel BenakLaboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia.
Stepanka BenakovaLaboratory of Pancreatic Islet Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia.
Lydie Plecita-HlavataLaboratory of Pancreatic Islet Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia.
Marketa HlavackovaLaboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia.
Czech Academy of Sciences · CZCharles University · CZCzech Academy of Sciences, Institute of Physiology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapidly developing research field of epitranscriptomics has recently emerged into the spotlight of researchers due to its vast regulatory effects on gene expression and thereby cellular physiology and pathophysiology. N

Indexed as

Diabetes Mellitus, Type 2AdenosineHumansRNARNA, MessengerRNA Processing, Post-TranscriptionalAdenosineRNARNA, Messengerdiabetesepigeneticsepitranscriptomicsm6Am6AmRNAT2DMtype 2 diabetes mellitus

Identifiers

PMID37484960
PMCPMC10360938
OpenAlexW4383533993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.